Tuesday, December 1, 2020
No menu items!

Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

Must Read

Team ‘Bombhaat’ has fun with science

The staff behind sci-fi Telugu flick ‘Bombhaat’, talk about their try at making a low-budget, lighthearted movie in...

Biden Weighs Rahm Emanuel For Transportation Secretary

CHICAGO: President-elect Joe Biden is contemplating former Chicago Mayor Rahm Emanuel, a considerable and considerably divisive determine...

Australia vs India: Virat Kohli on verge of breaking an impressive record held by Sachin Tendulkar

Although India have already misplaced the three-match ODI collection towards Australia, there’s considerably of a silver lining for...


Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

Phase-III human medical trial of the COVID-19 vaccine developed by Oxford University.

Pune:

The phase-III human medical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will start on the Sassoon General Hospital in Pune subsequent week.

Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe informed this to PTI on Saturday.

“The phase-III trial of ”Covishield” vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. Around 150 to 200 volunteers will be administered the vaccine candidate dose,” he mentioned.

“From Saturday, the hospital started enrolling volunteers for the trial. Those who are willing to volunteer for the vaccination should contact the hospital,” he mentioned.

Under phase-II, trials had been carried out at Bharti Vidyapeeth Medical College and in addition KEM Hospital within the metropolis.

The SII has partnered with British-Swedish pharma firm AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.

Earlier this month, the SII had paused the medical trials of the vaccine candidate within the nation.

The Drugs Controller General of India (DCGI) had on September 11 directed the SII to droop any new recruitmentin the phase-II and III medical trial of the vaccine until additional orders after AstraZeneca paused the trials in different nations due to “an unexplained illness” in a participant within the research.

However, on September 15, the DCGI gave permission to the SII to renew medical trial of the vaccine.



Source link

Latest News

Team ‘Bombhaat’ has fun with science

The staff behind sci-fi Telugu flick ‘Bombhaat’, talk about their try at making a low-budget, lighthearted movie in...

Biden Weighs Rahm Emanuel For Transportation Secretary

CHICAGO: President-elect Joe Biden is contemplating former Chicago Mayor Rahm Emanuel, a considerable and considerably divisive determine in Democratic Party politics, to...

Australia vs India: Virat Kohli on verge of breaking an impressive record held by Sachin Tendulkar

Although India have already misplaced the three-match ODI collection towards Australia, there’s considerably of a silver lining for the numerous Indian cricket followers....

Amazon Says Sellers Racked Up More Than $4.8 Billion In Sales Over Weekend

Amazon.com Inc stated on Tuesday unbiased companies promoting on its platform crossed $4.Eight billion in worldwide gross sales from Black Friday via Cyber...

Netflix To Make Korean Version Of Hit Spanish Series ‘Money Heist’

Los Angeles: Netflix is growing a South Korean adaptation of its Spanish-language fantasy crime sequence “Money Heist” (“La Casa De Papel”). ...

More Articles Like This